Evidence map›Paper›PMID 36043446›Full record

ArticleInfluenza and other respiratory viruses2022

Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai, March 7-31, 2022.

Xiangshi Wang, Hailing Chang, He Tian, Yanfeng Zhu, Jingjing Li, Zhongqiu Wei, Yixue Wang, Aimei Xia, Yanling Ge, Gongbao Liu and 4 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiangshi WangDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Hailing ChangDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
He TianDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Yanfeng ZhuDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Jingjing LiDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Zhongqiu WeiDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Yixue WangPaediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Aimei XiaDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Yanling GeDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Gongbao LiuDivision of Medical Administration, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Jiehao CaiDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Qirong ZhuDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Xiaowen ZhaiDepartment of Hematology and Oncology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Mei ZengDepartment of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.ORCID 0000-0002-3491-5298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to understand the epidemiological and clinical characteristics of pediatric SARS-CoV-2 infection during the early stage of Omicron variant outbreak in Shanghai.

methodsThis study included local COVID-19 cases <18 years in Shanghai referred to the exclusively designated hospital from March 7 to March 31, 2022. Clinical data, epidemiological exposure, and COVID-19 vaccination status were collected. Relative risks (RRs) were calculated to assess the effect of vaccination on symptomatic infection and febrile disease.

resultsA total of 376 pediatric cases of COVID-19 (median age: 6.0 ± 4.2 years) were referred to the designated hospital, including 257 (68.4%) symptomatic cases and 119 (31.6%) asymptomatic cases. Of the 307 (81.6%) children ≥3 years eligible for COVID-19 vaccination, 110 (35.8%) received two doses of vaccines. The median interval between the completion of two-dose vaccination and infection was 3.5 (interquartile range [IQR]: 3, 4.5) months. Compared with no vaccination, two-dose COVID-19 vaccination reduced the risks of symptomatic infection and febrile disease by 35% (RR 0.65, 95% confidence interval [CI]: 0.53-0.79) and 33% (RR 0.64, 95% CI: 0.51-0.81) among confirmed cases. Eighty-four percent of symptomatic cases had fever (mean duration: 1.7 ± 1.0.8 days), 40.5% had cough, and 16.4% had transient leukopenia. Three hundred and seven (81.6%) had an epidemiological exposure in household (69.1%), school (21.8%), and residential area (8.8%).

conclusionThe surge of pediatric COVID-19 cases and multiple transmission model reflect wide dissemination of Omicron variant in the community. Asymptomatic infection is common among Omicron-infected children. COVID-19 vaccination can offer some protection against symptomatic infection and febrile disease.

Indexed as

COVID-19ChildChild, PreschoolChinaCOVID-19 VaccinesDisease OutbreaksHumansInfantSARS-CoV-2COVID-19 VaccineschildrenCOVID-19 vaccineOmicron SARS-CoV-2 variant

Identifiers

PMID36043446
PMCPMC9530495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.